LCID
Lucid Group, Inc.
LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
MCD
McDonald's Corporation
MCD has a slight edge over LCID overall, supported by lower modeled downside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MCD Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Stable |
MCD's profitability and cash flow are currently strong, and its revenue and balance sheet are stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
MCD PE Valuation
MCD has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MCD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| High |
Analysts expect MCD's earnings to grow and its profitability to improve, with its revenue holding steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
MCD has the stronger earnings trend. Trailing diluted EPS is down 224% for LCID versus MCD up 0.4%.
MCD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.34 | +17% |
| Q3 2024 | $11.38 | +0.4% |
| Q2 2024 | $11.42 | +5.3% |
| Q1 2024 | $11.77 | +27% |
| Q4 2023 | $11.56 | +39% |
| Q3 2023 | $11.34 | +43% |
| Q2 2023 | $10.85 | +34% |
| Q1 2023 | $9.30 | -1.8% |
| Q4 2022 | $8.33 | -17% |
MCD earned $11.38 per share over the past year, about the same as the year before.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over MCD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
MCD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.2B | +1.1% |
| Q2 2026 | $7.1B | +3.7% |
| Q1 2026 | $6.5B | +9.4% |
| Q4 2025 | $7B | +9.7% |
| Q3 2025 | $7.1B | +3% |
| Q2 2025 | $6.8B | +5.4% |
| Q1 2025 | $6B | -3.5% |
| Q4 2024 | $6.4B | -0.3% |
MCD's revenue has grown year over year for six quarters in a row: $7.2B last quarter, up 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +2.8 points |
| Q2 2026 | 47% | -0.2 points |
| Q1 2026 | 45% | +0.9 points |
| Q4 2025 | 45% | +0.1 points |
| Q3 2025 | 47% | +1 points |
| Q2 2025 | 47% | +2.2 points |
| Q1 2025 | 44% | +0.1 points |
| Q4 2024 | 45% | +1.2 points |
MCD has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
MCD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.1B | -11% |
| Q2 2026 | $2B | +58% |
| Q1 2026 | $1.7B | -7.8% |
| Q4 2025 | $1.6B | -10% |
| Q3 2025 | $2.4B | +24% |
| Q2 2025 | $1.3B | +18% |
| Q1 2025 | $1.9B | +1.8% |
| Q4 2024 | $1.8B | +5.3% |
MCD has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
MCD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -2.7M shares |
| 1 year | -1.1% | -7.9M shares |
| 3 years | -2.5% | -18.4M shares |
MCD has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $519M |
| Q2 2026 | $856M |
| Q1 2026 | $396M |
| Q4 2025 | $573M |
| Q3 2025 | $501M |
| Q2 2025 | $505M |
| Q1 2025 | $477M |
| Q4 2024 | $503M |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MCD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.9x | Moderate |
| Q2 2026 | 2.9x | Moderate |
| Q1 2026 | 3.0x | Moderate |
| Q4 2025 | 3.2x | Elevated |
| Q3 2025 | 3.1x | Elevated |
| Q2 2025 | 3.2x | Elevated |
| Q1 2025 | 3.1x | Elevated |
| Q4 2024 | 3.1x | Elevated |
MCD's net debt is about 2.9 years of its operating earnings (EBITDA), down from 3.1 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
MCD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.2 | Neutral |
| Stochastic | 76.5 | Neutral |
MCD's weekly RSI is 54 (neutral) and its Stochastic is 77 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
MCD PE vs Consumer Cyclical Sector
| Metric | MCD | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
MCD has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
MCD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $250.4 | 9.3% above |
| 20 week MA | $260.1 | 5.2% above |
| 50 week MA | $286.6 | 4.5% below |
| 100 week MA | $295.0 | 7.2% below |
| 200 week MA | $287.9 | 5% below |
MCD has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
MCD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $198.2 | $211.4 | +6.7% |
| 2021 | $211.4 | $266.0 | +26% |
| 2022 | $266.0 | $267.6 | +0.6% |
| 2023 | $267.6 | $296.5 | +11% |
| 2024 | $296.5 | $293.6 | -1% |
| 2025 | $293.6 | $310.7 | +5.8% |
| 2026 YTD | $310.7 | $273.6 | -12% |
MCD has the edge over LCID on returns for 2026, with the stronger performance.